Filing Flows › Comparisons › TNXP vs OCUL
Tonix Pharmaceuticals Holding vs Ocular Therapeutix: TNXP and OCUL compared
Tonix Pharmaceuticals Holding is the larger company: $13.5M of revenue in its latest quarter (Q2 2026) against $13.5M for Ocular Therapeutix (Q2 2026). Tonix Pharmaceuticals Holding is growing faster (+578% against +0.1% a year earlier). Tonix Pharmaceuticals Holding is more profitable, with an operating margin of -314.1% against -609.3%.
Where the money goes: TNXP and OCUL
Tonix Pharmaceuticals Holding (TNXP) · Q2 2026
Tonix Pharmaceuticals Holding, Q2 2026: revenue $13.5M (+578% year over year), operating margin -314.1%, net loss $40.6M, operating cash flow −$42.2M. The chart follows the revenue to costs, profit and cash.
Ocular Therapeutix (OCUL) · Q2 2026
Ocular Therapeutix, Q2 2026: revenue $13.5M (+0.1% year over year), operating margin -609.3%, net loss $78.8M, operating cash flow −$67.3M. The chart follows the revenue to costs, profit and cash.
| Tonix Pharmaceuticals Holding (TNXP) | Ocular Therapeutix (OCUL) | |
|---|---|---|
| Latest quarter | Q2 2026 | Q2 2026 |
| Revenue | $13.5M | $13.5M |
| Revenue growth, Y/Y | +578% | +0.1% |
| Operating margin | -314.1% | -609.3% |
| Net earnings | −$40.6M | −$78.8M |
| Net margin | -299.4% | -584.5% |
| Operating cash flow | −$42.2M | −$67.3M |
Where the revenue comes from
Tonix Pharmaceuticals Holding
- Tonmya: $11.0M (81%)
- Zembrace Symtouch: $2.0M (15%)
- Tosymra: $594K (4%)
Questions
Which is bigger, Tonix Pharmaceuticals Holding or Ocular Therapeutix?
Tonix Pharmaceuticals Holding is the larger company: $13.5M of revenue in its latest quarter (Q2 2026) against $13.5M for Ocular Therapeutix (Q2 2026).
Is Tonix Pharmaceuticals Holding or Ocular Therapeutix growing faster?
Tonix Pharmaceuticals Holding is growing faster (+578% against +0.1% a year earlier).
Which is more profitable, Tonix Pharmaceuticals Holding or Ocular Therapeutix?
Tonix Pharmaceuticals Holding is more profitable, with an operating margin of -314.1% against -609.3%.
More: Tonix Pharmaceuticals Holding earnings · how Tonix Pharmaceuticals Holding makes money · Ocular Therapeutix earnings · how Ocular Therapeutix makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Aug 10, 2026; 10-Q filed Aug 3, 2026). Fiscal quarters can end on different dates. Not investment advice.